Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pilot study of thalidomide in myelodysplastic syndrome yields encouraging results

Aug. 21, 2001

Phase I study successful for Prescient NeuroPharma's anhydrovinblastine

Aug. 20, 2001

Geron and Kyowa Hakko select telomerase inhibitor for development

Aug. 20, 2001

Encouraging phase I results reported for Supratek's lead oncology product

Aug. 20, 2001

Onyx regains development rights for nonintravenous administration of ONYX-015

Aug. 20, 2001

Zeltia and Ortho Biotech announce licensing agreement for ET-743

Aug. 14, 2001

Strategy for systemic administration of Reolysin explored

Aug. 13, 2001

Merck & Co. reports novel farnesyltransferase inhibitor with excellent cell potency

Aug. 13, 2001

First nonpeptide somatotropin sst3 antagonists reported

Aug. 13, 2001

Urokinase inhibitors with antiangiogenic activity reported by Abbott

Aug. 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...